ECG Market Forecast to $11.3 Billion by 2028

-

According to research report the global ECG Market totaled an estimated $8.1 billion in revenue in 2023, but market research points to strong growth in the coming years. By 2028, the diagnostic ECG market is expected to reach $11.3 billion, reflecting a healthy compound annual growth rate of 6.9%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173

Rising prevalence of cardiovascular disease (CVD) among global populations represents a primary catalyst propelling the need for advanced ECG devices aimed at early diagnosis and monitoring. Aging populations, expanding rates of lifestyle diseases like hypertension and diabetes, and growing case numbers of conditions like atrial fibrillation are all widening the CVD burden.

Emerging technologies that enable mobile and wireless heart monitoring as well as advanced ECG devices leveraging artificial intelligence algorithms are also facilitating market expansion. These innovations allow for more patient-friendly testing, remote monitoring, and rapid analysis of screening results via smart data analytics.

However, a global shortage of skilled professionals to correctly conduct and interpret ECG tests poses a restraint. Training additional specialists to bridge this 4 million physician deficit will be key to ensuring maximum patient access to life-saving heart diagnostics.

Among different products, resting ECG devices currently hold the majority share of the diagnostic ECG market due to affordability, ease of use, and utility as a first-line heart disease screening tool. Over the forecast period though, AI-powered smart ECG devices are predicted to see the fastest adoption. These next-gen diagnostic aids integrate seamlessly with electronic health records, enabling streamlined workflows.  

By lead type, standard 12-lead ECG configurations dominate among emergency clinicians thanks to their ability to rapidly detect heart attack complications. But more compact 3 to 6 lead ambulatory and wearable monitors are rising in popularity for daily CVD checks.

Geographically, well-established healthcare systems and an advanced base of CVD patients position North America as the prime market. However, developing global economies offer the ripest opportunities as cardiovascular disease rates climb and investments expand healthcare access. Companies looking to capitalize on the high-growth diagnostic ECG industry would do well to focus expansion plans there.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173

In summary, with strong momentum as global risk factors boost demand for CVD screening, the diagnostic ECG market looks positioned to chart impressive gains worldwide. An expected value approaching $11 billion within five years highlights the potential rewards for manufacturers with insights into the trends and competitors shaping success.

Related Links:

https://www.prnewswire.com/news-releases/diagnostic-electrocardiograph-ecg-market-worth-11-3-billion--marketsandmarkets-301912393.html

https://www.linkedin.com/pulse/diagnostic-electrocardiograph-market-size-share-1rchf?trk=article-ssr-frontend-pulse_more-articles_related-content-card

https://www.linkedin.com/pulse/ecg-market-set-reach-113-billion-2028-unveiling-cxedf?trk=article-ssr-frontend-pulse_more-articles_related-content-card

https://www.marketsandmarkets.com/Market-Reports/Diagnostic-ECG-global-Market-173.html

https://www.marketsandmarkets.com/PressReleases/diagnostic-ecg.asp

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in their ow
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d
Read more

Stable Isotope Labeled Compounds Market Growth: Trends and Opportunities

-
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The H-2 labeled compounds segment accounted for the largest share of the stable isotope labeled compounds market. Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this
Read more